SCHEMBL12438567

SCHEMBL12438567

CC(C)C1=NOC(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(OCCN3CCOCC3)n2)C1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12438468 0.94 IGF1R (0.67) IGF1R
SCHEMBL14162070 0.90 IGF1R (0.65) IGF1R
SCHEMBL12438466 0.84 IGF1R (0.68) IGF1R
SCHEMBL12439798 0.84 IGF1R (0.65) IGF1R
SCHEMBL4472934 0.81 IGF1R (1.00) IGF1R
SCHEMBL14311644 0.77 IGF1R (0.66) IGF1R
SCHEMBL12438527 0.77 IGF1R (0.64) IGF1R
SCHEMBL4468090 0.75 IGF1R (1.00) IGF1R
SCHEMBL14050578 0.74 IGF1R (0.68) IGF1R
SCHEMBL11350347 0.74 IGF1R (1.00) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841760-B1 PYRIMIDINE DERIVATIVES AS KINASE MODULATORS AND METHOD OF USE EXELIXIS INC (US) 2011-08-10 EP disclosed
WO-2008005538-A2 METHODS OF USING IGF1R AND ABL KINASE MODULATORS EXELIXIS, INC. (US) 2008-01-10 WO disclosed